keyword
https://read.qxmd.com/read/38696394/hepcidin-in-contrast-to-heparin-binding-protein-does-not-portend-acute-kidney-injury-in-patients-with-community-acquired-septic-shock
#1
JOURNAL ARTICLE
Jon Olinder, Matilda Jovanovic Stjernqvist, Albin Lindén, Evelina Thaphikul Salomonsson, Martin Annborn, Heiko Herwald, Cecilia Rydén
BACKGROUND: Acute kidney injury (AKI) is a common and severe complication in patients treated at an Intensive Care Unit (ICU). The pathogenesis of AKI has been reported to involve hypoperfusion, diminished oxygenation, systemic inflammation, and damage by increased intracellular iron concentration. Hepcidin, a regulator of iron metabolism, has been shown to be associated with sepsis and septic shock, conditions that can result in AKI. Heparin binding protein (HBP) has been reported to be associated with sepsis and AKI...
2024: PloS One
https://read.qxmd.com/read/38695590/computed-tomography-assessed-sarcopenia-predicts-mortality-in-kidney-transplant-candidates
#2
JOURNAL ARTICLE
Harun Coban, Dilek Barutcu Atas, Murat Tugcu, Meltem Kursun, Canan Cimsit, Ebru Asicioglu, Hakki Arikan, Serhan Tuglular, Arzu Velioglu
OBJECTIVES: Sarcopenia is common in chronic kidney disease and associated with increased mortality. We investigated the prevalence of sarcopenia, defined as low muscle mass by the psoas muscle index, in endstage renal disease patients on waiting lists for kidney transplant and determined its association with prognostic nutritional index, C-reactive protein-toalbumin ratio, cardiovascular events, and mortality. MATERIALS AND METHODS: Our study included 162 patients with end-stage renal disease and 87 agematched healthy controls...
March 2024: Experimental and Clinical Transplantation
https://read.qxmd.com/read/38693706/machine-perfusion-organ-preservation-highlights-from-the-american-transplant-congress-2023
#3
JOURNAL ARTICLE
Isabella Faria, Stalin Canizares, Lene Devos, Charles Strom, Narendra Battula, Devin E Eckhoff, Paulo N Martins
The American Transplant Congress (ATC) 2023, held in San Diego, California, emerged as a pivotal platform showcasing the latest advancements in organ machine perfusion, a key area in solid organ and tissue transplantation. This year's congress, attended by over 4500 participants, including leading experts, emphasized innovations in machine perfusion technologies across various organ types, including liver, kidney, heart, and lung. A total of 85 abstracts on organ machine perfusion were identified. Noteworthy advancements included the use of normothermic machine perfusion in mitigating ex-situ reperfusion injury in liver transplantation, the potential of biomarkers in assessing organ quality, and the impact of machine perfusion on graft survival and ischemic cholangiopathy incidence...
May 1, 2024: Artificial Organs
https://read.qxmd.com/read/38691919/unlocking-renal-restoration-mesaconine-from-aconitum-plants-restore-mitochondrial-function-to-halt-cell-apoptosis-in-acute-kidney-injury
#4
JOURNAL ARTICLE
Yixin Rui, Xiumeng Zhang, Xinran Min, Hongxiao Xie, Xiuying Ma, Funeng Geng, Rong Liu
Acute kidney injury (AKI) is characterized by a sudden decline in renal function. Traditional Chinese medicine has employed Fuzi for kidney diseases; however, concerns about neurotoxicity and cardiotoxicity have constrained its clinical use. This study explored mesaconine, derived from processed Fuzi, as a promising low-toxicity alternative for AKI treatment. In this study, we assessed the protective effects of mesaconine in gentamicin (GM)-induced NRK-52E cells and AKI rat models in vitro and in vivo, respectively...
April 30, 2024: International Immunopharmacology
https://read.qxmd.com/read/38691152/furosemide-stress-test-to-predict-acute-kidney-injury-progression-in-critically-ill-children
#5
JOURNAL ARTICLE
Sudarsan Krishnasamy, Aditi Sinha, Rakesh Lodha, Jhuma Sankar, Mohamad Tarik, Lakshmy Ramakrishnan, Arvind Bagga, Pankaj Hari
BACKGROUND: Furosemide stress test (FST) is a novel functional biomarker for predicting severe acute kidney injury (AKI); however, pediatric studies are limited. METHODS: Children 3 months to 18 years of age admitted to the intensive care unit (ICU) of a tertiary care hospital from Nov 2019 to July 2021 were screened and those who developed AKI stage 1 or 2 within 7 days of admission underwent FST (intravenous furosemide 1 mg/kg). Urine output was measured hourly for the next 6 h; a value > 2 ml/kg within the first 2 h was deemed furosemide responsive...
April 30, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38689404/cardiac-surgery-associated-acute-kidney-injury-csa-aki
#6
JOURNAL ARTICLE
Florian G Scurt, Katrin Bose, Peter R Mertens, Christos Chatzikyrkou, Carolin Herzog
Acute kidney injury (AKI) is a common and serious complication of cardiac surgery that has a significant impact on patient morbidity and mortality. The Kidney Disease Improving Global Outcomes (KDIGO) definition of AKI is widely used to classify and identify AKI associated with cardiac surgery (CSA-AKI) based on changes in serum creatinine and/or urine output. There are various pre-, intra-, and postoperative risk factors for the development of CSA-AKI which should be recognized and addressed as early as possible to expedite its diagnosis, reduce its occurrence and prevent or ameliorate its devastating complications...
May 1, 2024: Kidney360
https://read.qxmd.com/read/38689358/alzheimer-s-and-neurodegenerative-disease-biomarkers-in-blood-predict-brain-atrophy-and-cognitive-decline
#7
JOURNAL ARTICLE
Heather E Dark, Yang An, Michael R Duggan, Cassandra Joynes, Christos Davatzikos, Guray Erus, Alexandria Lewis, Abhay R Moghekar, Susan M Resnick, Keenan A Walker
BACKGROUND: Although blood-based biomarkers have been identified as cost-effective and scalable alternatives to PET and CSF markers of neurodegenerative disease, little is known about how these biomarkers predict future brain atrophy and cognitive decline in cognitively unimpaired individuals. Using data from the Baltimore Longitudinal Study of Aging (BLSA), we examined whether plasma biomarkers of Alzheimer's disease (AD) pathology (amyloid-β [Aβ42/40 ], phosphorylated tau [pTau-181]), astrogliosis (glial fibrillary acidic protein [GFAP]), and neuronal injury (neurofilament light chain [NfL]) were associated with longitudinal brain volume loss and cognitive decline...
April 30, 2024: Alzheimer's Research & Therapy
https://read.qxmd.com/read/38689335/a-retrospective-clinical-analysis-of-11-cases-of-pecoma-from-different-sites
#8
REVIEW
Jinbowen Yan, Dan Zhou, Yifei Wang, Bowen Yang, Yuefeng Wang, Kaili Zhang, Shuo Zhang, Bo Zhang, Qingwei Meng, Qiubo Lv
PURPOSE: The objective of this paper is to offer a thorough examination of the clinical presentations, etiology, and treatment strategies associated with perivascular epithelioid cell tumors (PEComas). METHODS: This retrospective study examined the comprehensive archival data of PEComa cases diagnosed at Beijing Hospital from 2015 to 2023. The pathology slides of all patients were thoroughly reassessed by two experienced pathologists. A thorough retrospective analysis was undertaken, incorporating clinicopathological data including gender, age at diagnosis, initial clinical manifestations, signs, disease onset site, tumor markers, imaging findings, therapeutic modalities, pathological features, immunohistochemical profiles, treatment responses, and prognostic indicators...
April 30, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38689160/the-current-use-of-proteomics-and-metabolomics-in-glomerulonephritis-a-systematic-literature-review
#9
REVIEW
Elin Davies, Andrew Chetwynd, Garry McDowell, Anirudh Rao, Louise Oni
BACKGROUND: Glomerulonephritis inherently leads to the development of chronic kidney disease. It is the second most common diagnosis in patients requiring renal replacement therapy in the United Kingdom. Metabolomics and proteomics can characterise, identify and quantify an individual's protein and metabolite make-up. These techniques have been optimised and can be performed on samples including kidney tissue, blood and urine. Utilising omic techniques in nephrology can uncover disease pathophysiology and transform the diagnostics and treatment options for glomerulonephritis...
April 30, 2024: Journal of Nephrology
https://read.qxmd.com/read/38689072/screening-impacts-of-tilmicosin-induced-hepatic-and-renal-toxicity-in-rats-protection-by-rhodiola-rosea-extract-through-the-involvement-of-oxidative-stress-antioxidants-and-inflammatory-cytokines-biomarkers
#10
JOURNAL ARTICLE
Salwa A Elgendy, Mohamed Mohamed Soliman, Mustafa Shukry, Lina Abdelhady Mohammed, Hend Elsayed Nasr, Saad Althobaiti, Daklallah A Almalki, Khalid S Alotaibi, Shatha B Albattal, Heba A Elnoury
Tilmicosin (TIL) is a semisynthetic macrolide antibiotic with a broad spectrum of activity derived from tylosin. TIL is effective in the treatment of bovine and ovine respiratory diseases caused by different microbes. In parallel, Rhodiola rosea (RHO) is a popular herbal remedy because of its anti-inflammatory and antioxidant qualities. The experiment lasted for 12 days. Depending on the experimental group, the animals received either distilled water or RHO root extract dissolved in distilled water for 12 days through a stomach tube, and the single subcutaneous injection on day 6 of the experiment of either 500 μL of 0...
April 30, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38688639/robust-rat-and-mouse-models-of-bilateral-renal-ischemia-reperfusion-injury
#11
JOURNAL ARTICLE
Tanya Smith, Aeliya Zaidi, Charlotte Victoria Maynard Brown, Gilda Pino-Chavez, Timothy Bowen, Soma Meran, Donald Fraser, Rafael Chavez, Usman Khalid
BACKGROUND/AIM: Acute and chronic kidney diseases are a major contributor to morbidity and mortality worldwide, with no specific treatments currently available for these. To enable understanding the pathophysiology of and testing novel treatments for acute and chronic kidney disease, a suitable in vivo model of kidney disease is essential. In this article, we describe two reliable rodent models (rats and mice) of efficacious kidney injury displaying acute to chronic kidney injury progression, which is also reversible through novel therapeutic strategies such as ischemic preconditioning (IPC)...
2024: In Vivo
https://read.qxmd.com/read/38688207/honing-the-hunt-a-comprehensive-review-of-cell-free-tumor-dna-to-predict-neoadjuvant-therapy-efficacy-in-bladder-cancer
#12
REVIEW
Caio V Suartz, Lucas Motta Martinez, Maurício D Cordeiro, Luiz A A Botelho, Fábio P Gallutti, José M Mota, Katia R M Leite, Paul Toren, William C Nahas, Leopoldo A Ribeiro-Filho
OBJECTIVE: To provide an updated view on the role of cell-free DNA as a predictor of pathological response to neoadjuvant therapy in patients with muscle-invasive bladder cancer. METHODS: A systematic review was conducted from September 2023 to October 2023. Selected studies from the MEDLINE and clinical trial databases were critically analyzed regarding the clinical efficacy of cell-free DNA as a predictive instrument after neoadjuvant therapy in bladder cancer...
April 6, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38687867/long-non-coding-rna-neat1-nlrp3-inflammasome-and-acute-kidney-injury
#13
JOURNAL ARTICLE
Rui Xue, Wai Han Yiu, Kam Wa Chan, Sarah W Y Lok, Yixin Zou, Jingyuan Ma, Hongyu Li, Loretta Y Y Chan, Xiao Ru Huang, Kar Neng Lai, Hui Yao Lan, Sydney C W Tang
BACKGROUND: Acute kidney injury (AKI) is common in hospitalized patients and is associated with high mortality. Inflammation plays a key role in the pathophysiology of AKI. Long non-coding RNAs (lncRNAs) are increasingly recognized as regulators of the inflammatory and immune response, but its role in AKI remains unclear. METHODS: We explored the role of lncRNA Neat1 in (1) a cross-sectional and a longitudinal cohort of AKI in human; (2) three murine models of septic and aseptic AKI and (3) cultured C1...
April 30, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38687125/utility-of-blood-biomarkers-to-predict-marrow-iron-stores-in-children
#14
JOURNAL ARTICLE
Shilpa Sharma, Renata C Pereira, Elizabeta Nemeth, Mark R Hanudel, Joachim H Ix, Isidro B Salusky, Tomas Ganz
BACKGROUND: Iron deficiency is common in children with kidney failure, but current guidelines are based on biomarkers of iron stores that may be influenced by inflammation. This is the first study that examined which serum iron indices were associated with stainable marrow iron stores (the gold standard) in this population with kidney failure who underwent bone biopsies. METHODS: This cross-sectional study enrolled 71 clinically stable children and young adults receiving dialysis who underwent bone biopsy for chronic kidney disease-mineral bone disorder between 2007 through 2011...
April 30, 2024: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/38686855/inflammation-and-adverse-outcomes-in-patients-with-acute-ischemic-stroke-with-and-without-chronic-kidney-disease
#15
JOURNAL ARTICLE
Xiaoyu Wang, Yuesong Pan, Runhua Zhang, Mengxing Wang, Xia Meng, Zixiao Li, Hao Li, Yilong Wang, Xingquan Zhao, Yongjun Wang, Gaifen Liu
BACKGROUND: Elevated white blood cell count, fibrinogen levels, and lower levels of albumin signify higher systemic inflammatory response, hypercoagulable state, and poorer nutritional status, respectively. However, a consistent conclusion could not be drawn on whether the association between inflammatory markers and cardiovascular disease was affected by the presence of chronic kidney disease (CKD). We aimed to explore the association between inflammation and adverse outcomes in patients with acute ischemic stroke (AIS), as well as whether this association differs due to the presence of CKD...
April 30, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38684845/a-link-between-circulating-immune-complexes-and-acute-kidney-injury-in-human-visceral-leishmaniasis
#16
JOURNAL ARTICLE
Gabriela Corrêa-Castro, Maria Luciana Silva-Freitas, Ludmila de Paula, Leonardo Soares Pereira, Maria Rita Teixeira Dutra, Hermano Gomes Albuquerque, Glaucia Cota, Caroline de Azevedo Martins, Alda Maria Da-Cruz, Adriano Gomes-Silva, Joanna Reis Santos-Oliveira
Visceral leishmaniasis (VL) is an infectious disease caused by Leishmania infantum. Clinically, VL evolves with systemic impairment, immunosuppression and hyperactivation with hypergammaglobulinemia. Although renal involvement has been recognized, a dearth of understanding about the underlying mechanisms driving acute kidney injury (AKI) in VL remains. We aimed to evaluate the involvement of immunoglobulins (Igs) and immune complexes (CIC) in the occurrence of AKI in VL patients. Fourteen VL patients were evaluated between early treatment and 12 months post-treatment (mpt)...
April 30, 2024: Scientific Reports
https://read.qxmd.com/read/38684762/multi-omics-pan-cancer-study-of-sptbn2-and-its-value-as-a-potential-therapeutic-target-in-pancreatic-cancer
#17
JOURNAL ARTICLE
Hongliang Chang, Hong Chen, Taiheng Ma, Kexin Ma, Yi Li, Lida Suo, Xiangnan Liang, Kunyu Jia, Jiahong Ma, Jing Li, Deguang Sun
SPTBN2 is a protein-coding gene that is closely related to the development of malignant tumors. However, its prognostic value and biological function in pan-cancer, especially pancreatic cancer (PAAD), have not been reported. In the present study, a novel exploration of the value and potential mechanism of SPTBN2 in PAAD was conducted using multi-omics in the background of pan-cancer. Via various database analysis, up-regulated expression of SPTBN2 was detected in most of the tumor tissues examined. Overexpression of SPTBN2 in PAAD and kidney renal clear cell cancer patients potentially affected overall survival, disease-specific survival, and progression-free interval...
April 29, 2024: Scientific Reports
https://read.qxmd.com/read/38684708/identifying-therapeutic-targets-for-cancer-among-2074-circulating-proteins-and-risk-of-nine-cancers
#18
JOURNAL ARTICLE
Karl Smith-Byrne, Åsa Hedman, Marios Dimitriou, Trishna Desai, Alexandr V Sokolov, Helgi B Schioth, Mine Koprulu, Maik Pietzner, Claudia Langenberg, Joshua Atkins, Ricardo Cortez Penha, James McKay, Paul Brennan, Sirui Zhou, Brent J Richards, James Yarmolinsky, Richard M Martin, Joana Borlido, Xinmeng J Mu, Adam Butterworth, Xia Shen, Jim Wilson, Themistocles L Assimes, Rayjean J Hung, Christopher Amos, Mark Purdue, Nathaniel Rothman, Stephen Chanock, Ruth C Travis, Mattias Johansson, Anders Mälarstig
Circulating proteins can reveal key pathways to cancer and identify therapeutic targets for cancer prevention. We investigate 2,074 circulating proteins and risk of nine common cancers (bladder, breast, endometrium, head and neck, lung, ovary, pancreas, kidney, and malignant non-melanoma) using cis protein Mendelian randomisation and colocalization. We conduct additional analyses to identify adverse side-effects of altering risk proteins and map cancer risk proteins to drug targets. Here we find 40 proteins associated with common cancers, such as PLAUR and risk of breast cancer [odds ratio per standard deviation increment: 2...
April 29, 2024: Nature Communications
https://read.qxmd.com/read/38684379/increased-risk-of-acute-kidney-injury-in-the-first-part-of-an-ultra-trail-implications-for-abandonment
#19
JOURNAL ARTICLE
Jean-Charles Vauthier, Charlie Touze, Benoit Mauvieux, Corentin Hingrand, Pierre-Louis Delaunay, Stéphane Besnard, Romain Jouffroy, Philippe Noirez, Patrice Maboudou, Cassandra Parent, Elsa Heyman, Mathias Poussel
Acute kidneys injuries (AKIs) have been described in marathon and trail running. The currently available data allows assessment of before/after comparisons but does not allow an analysis of what happens during the race. A multidisciplinary assessment protocol was performed during the first trail of Clécy (Normandy France) in November 2021. This allowed an initial assay to be carried out, then at the end of each of the 6 loops of 26 km, and finally after 24 h of recovery. The race extends over 156 km in hilly terrain and 6000 m of elevation gain (D+)...
May 2024: Physiological Reports
https://read.qxmd.com/read/38683229/-recent-developments-in-acute-kidney-injury-definition-biomarkers-subphenotypes-and-management
#20
REVIEW
Timo Mayerhöfer, Fabian Perschinka, Michael Joannidis
Acute kidney injury (AKI) is a common problem in critically ill patients and is associated with increased morbidity and mortality. Since 2012, AKI has been defined according to the KDIGO (Kidney Disease Improving Global Outcome) guidelines. As some biomarkers are now available that can provide useful clinical information, a new definition including a new stage 1S has been proposed by an expert group of the Acute Disease Quality Initiative (ADQI). At this stage, classic AKI criteria are not yet met, but biomarkers are already positive defining subclinical AKI...
April 29, 2024: Medizinische Klinik, Intensivmedizin und Notfallmedizin
keyword
keyword
88236
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.